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Cells
Colorectal carcinomas (CRCs) might contain a subpopula-
tion of tumorigenic, putative cancer stem cells that can
replenish the tumor. Gaiser et al (Am J Pathol 2011, 178:
1478–1488) analyzed isolated cell populations from CRC
cell lines and primary tumors using array comparative
genomic hybridization (aCGH) to compare genomic aber-
ration profiles between CD133 and CD133 cells. Three
of five CRC cell lines displayed both CD133 and CD133
cells, but tumorigenicity and genomic aberration profiles did
not differ significantly. Laser capture microdissection and
aCGH analysis of primary CRCs revealed genetic differences
betweenCD133andCD133cells, withCD133cells pos-
sessing a unique genomic aberration profile. These data
question the usefulness of cell lines in defining cancer stem
cell characteristics. Further, CD133 positivity points to a
genetically distinct cellular compartment, of possible tumor
initiating cells, in primary CRC.
MeCP2 Regulates Myofibroblast Differentiation
in Pulmonary Fibrosis
DNAmethylation represses -smoothmuscle actin (-SMA)
gene expression in fibroblasts, which is important in myofi-
broblast differentiation and fibrosis; however, the trans-act-
ing factors involved are not known. Hu et al (Am J Pathol
2011, 178:1500–1508) found that methyl CpG-binding pro-
tein 2 (MeCP2) binds the -SMA gene. Suppression of
MeCP2 gene expression (by siRNA or by knockdown in vivo
in mouse lung fibroblasts) significantly reduced -SMA
gene expression. In contrast, overexpressing MeCP2 in fi-
broblasts enhanced -SMA gene expression. In vivo studies
revealed that compared to their wild-type littermates,
MeCP2-deficient mice exhibited significantly decreased al-
veolar wall thickness, inflammatory cell infiltration, interstitial
collagen deposition, and myofibroblast differentiation in re-
sponse to experimentally induced lung fibrosis. MeCP2 is
thus essential for myofibroblast differentiation and pulmo-
nary fibrosis.
Value of Guinea Pigs in Assessing Plague
Subunit Vaccines
Suitable animal models for pneumonic plague, caused
by Yersinia pestis, are needed for vaccine efficacy testing.
Quenee et al (Am J Pathol 2011, 178:1689–1700) ex-
plored guinea pigs as a model system using Y. pestis
CO92. Infected guinea pigs developed lethal lung infec-tions with hemorrhagic necrosis, massive bacterial repli-
cation in the respiratory system, and blood-borne systemic
dissemination. The Y. pestis F1 capsule was not required for
pulmonary infection but was important for producing bu-
bonic plague. Immunization with the recombinant protein
LcrV or F1 capsule yielded robust humoral immune re-
sponses, but only LcrV produced partial protection against
pneumonic plague challenge. The vaccine variant rV10
elicited protection against pneumonic plague, demonstrat-
ing guinea pigs as a suitable nonhuman primate model for
assessing pneumonic plague vaccines.
Blocking Endometriosis at the Start
Bone marrow-derived endothelial progenitor cells (EPCs)
play an integral part in the establishment of endometrio-
sis, a debilitating disease characterized by growth of
ectopic endometrial tissue. Becker et al (Am J Pathol
2011, 178:1782–1791) examined the blood levels of
EPCs and mature circulating endothelial cells in a mouse
model of endometriosis. EPC concentrations paralleled
increases in the amount of endometriotic tissue, peaking
1 to 4 days after disease induction. Transplanted GFP-
positive endothelial cells were incorporated into endo-
metriotic lesions but not eutopic endometrium. Further,
treatment of endometriosis-bearing mice with the angio-
genesis inhibitor Lodamin significantly decreased EPC
levels and suppressed lesion growth. These data support
the potential clinical use of anti-angiogenic therapy as a
novel treatment for endometriosis.
MYC Oncogene Drives Hallmark Changes in
Prostatic Neoplasia
In prostate cancer, enlargement and increased numbers
of nucleoli are associated with premalignant prostate in-
traepithelial neoplasia (PIN) lesions and invasive adeno-
carcinomas. Koh et al (Am J Pathol 2011, 178:1824–
1834) found that activation of theMYC oncogene resulted
in enlarged nucleoli and increased nucleolar number in
prostate luminal epithelial cells in vivo. In vitro, MYC ex-
pression was needed for maintenance of nucleolar number
as well as gene expression in prostate cancer cells. Fibril-
larin (encoded by the MYC target gene FBL) was required
for proliferation, clonogenic survival, and proper ribosomal
RNA accumulation/processing in human prostate cancer
cells; it was also overexpressed in PIN lesions in the mouse
prostate and in human clinical prostate adenocarcinoma
and PIN lesions. Therefore,MYC overexpression provides a
molecular mechanism responsible for hallmark nucleolar
alterations in prostatic neoplasia.
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